KendrithMRowlandMD

Oncology • Urbana, IL

Physician

Join to view full profile

Are you Dr. Rowland?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 47 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
509 W University Ave
Urbana, IL 61801
Phone+1 217-383-6636

Fax+1 217-383-3466
Is this information wrong?

Summary

Dr. Kendrith Rowland, MD is an oncologist in Urbana, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Carle Foundation Hospital and Gibson Area Hospital and Health Services.

Education & Training

Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1980 - 1983
University of Illinois College of MedicineClass of 1980

Certifications & Licensure

IL State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma Start of enrollment: 2004 Jan 13
Completed
Phase 2
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Start of enrollment: 2005 Apr 14
Completed
Phase 2
Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2004 Dec 01
Completed
Phase 2
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2006 Mar 24
Completed
Phase 1, Phase 2
VEGF Trap in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2007 Jan 01
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2007 Aug 01
Completed
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 15
Completed
Phase 2
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Acute Pain Caused by Paclitaxel in Patients With Cancer Start of enrollment: 2009 Feb 01
Completed
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
Completed
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Start of enrollment: 2004 Sep 21
Completed
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Completed
Phase 2
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer Start of enrollment: 2016 Mar 01
Active, not recruiting
Phase 1
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Start of enrollment: 2017 Mar 31
Active, not recruiting
Phase 2
A Study of miRNA 371 in Patients With Germ Cell Tumors Start of enrollment: 2020 Jul 28
Recruiting
Join now to see all

Publications & Presentations

PubMed

Colon metastases as first clinical manifestation of lobular breast carcinoma with no subsequent evidence of breast disease.
Mohammed Isaac Abu Zaanona, Aishwarya Gulati, Kendrith M. Rowland> ;BMJ Case Reports. 2020 Nov 30
7 citations
A pilot feasibility randomized controlled trial adding behavioral counseling to supervised physical activity in prostate cancer survivors: behavior change in prostate ...
Linda Trinh, Arthur F. Kramer, Kendrith M. Rowland, Dominick A. Strom, Jaime N. Wong, Edward McAuley> ;Journal of Behavioral Medicine. 2021 Apr 1
6 citations
Dose-Response Effects of Acute Aerobic Exercise Duration on Cognitive Function in Patients With Breast Cancer: A Randomized Crossover Trial.
Elizabeth A. Salerno, Kendrith M. Rowland, Charles H. Hillman, Linda Trinh, Arthur F. Kramer, Edward McAuley> ;Frontiers in Psychology. 2020 Jul 14
46 citations
Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).
Roberto A. Leon-Ferre, Paul J. Novotny, Eric G. Wolfe, Stephanie S. Faubion, Kathryn J. Ruddy, Daniel Flora, Christopher S R Dakhil, Kendrith M. Rowland, Mark L Graham...> ;JNCI Cancer Spectrum. 2020 Feb 1
23 citations
Acute aerobic exercise effects on cognitive function in breast cancer survivors: a randomized crossover trial
Elizabeth A. Salerno, Kendrith M. Rowland, Arthur F. Kramer, Edward McAuley> ;BMC Cancer. 2019 Apr 23
1 citations
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)
Mark N. Stein, Yu-Hui Chen, Michael A. Carducci, Gary R. Hudes, Pauline M. Lerma, Winston Tan, Robert Dalune, Kendrith M. Rowland, Timothy M. Kuzel, Robert S. DiPaola> ;American Journal of Clinical Oncology. 2019 Apr 1
4 citations
Androgen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small ...
Jennifer Le-Rademacher, Kendrith M. Rowland, Pamela J. Atherton, Christopher S R Dakhil, Zhifu Sun, Angelina Tan, Lucy J. Schmidt, Phuong L. Nguyen, Carmen Radecki Bre...> ;The American Journal of Hospice & Palliative Care. 2019 Jan 2
23 citations
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial
Aminah Jatoi, Preston D. Steen, Pamela J. Atherton, Dennis F. Moore, Kendrith M. Rowland, Nguyet A. Le-Lindqwister, C. S. Adonizio, Anthony J. Jaslowski, Jeff A. Sloan...> ;Annals of Oncology. 2017 Aug 1
6 citations
Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B–cell non-Hodgkin ly...
Thomas E. Witzig, Patrick B. Johnston, Betsy LaPlant, Paul J. Kurtin, Levi Pederson, Dennis F. Moore, Nassim H. Nabbout, Daniel A. Nikcevich, Kendrith M. Rowland, Axel...> ;American Journal of Hematology. 2017 Oct 1
31 citations
A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer: North Central C...
Yujie Zhao, Nathan R. Foster, Jeffrey P. Meyers, Sachdev P. Thomas, Donald W. Northfelt, Kendrith M. Rowland, Bassam I. Mattar, David B. Johnson, Julian R. Molina, Sum...> ;Journal of Thoracic Oncology. 2015 Jan 1
43 citations
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT
Howard S. Hochster, Axel Grothey, Lowell L. Hart, Kendrith M. Rowland, Rafat Ansari, Steven R. Alberts, N. M. Chowhan, Ramesh K. Ramanathan, M. Keaton, John D. Hainswo...> ;Annals of Oncology. 2014 Jun 1
36 citations
Quality of life in MAP.3 (Mammary Prevention 3): A randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer
Elizabeth Maunsell, Paul E. Goss, Rowan T. Chlebowski, James N. Ingle, José E. Alés-Martínez, Gloria E. Sarto, Carol J. Fabian, Pascal Pujol, Amparao Ruiz, Andrew Cook...> ;Journal of Clinical Oncology. 2014 Apr 7
40 citations
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled ...
Paul E. Goss, Dawn L. Hershman, Angela M. Cheung, James N. Ingle, Sundeep Khosla, Vered Stearns, Haji Chalchal, Kendrith M. Rowland, Hyman B. Muss, Hannah M. Linden, J...> ;The Lancet. Oncology. 2014 Apr 1
6 citations
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Tr...
Winston Tan, Amylou C. Dueck, Patrick J. Flynn, Preston D. Steen, D. M. Anderson, Kendrith M. Rowland, Donald W. Northfelt, E. A. Perez> ;Annals of Oncology. 2013 Oct 1
251 citations
Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study
Glenwood D. Goss, Christopher J. O'Callaghan, Ian A. J. Lorimer, Ming-Sound Tsao, Gregory A. Masters, James R. Jett, Martin J. Edelman, Rogerio Lilenbaum, Hak Choy, Fa...> ;Journal of Clinical Oncology. 2013 Sep 20
36 citations
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9
Debra L. Barton, Kelli N. Burger, Paul J. Novotny, Tom R. Fitch, Sadhna Kohli, Gamini S. Soori, Mary B. Wilwerding, Jeff A. Sloan, Lisa A. Kottschade, Kendrith M. Rowl...> ;Supportive Care in Cancer. 2013 Apr 1
19 citations
14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers
Anna Bergamaschi, Jonna Frasor, Kristina Borgen, Adina Stanculescu, Patricia A. Johnson, Kendrith M. Rowland, Elizabeth L. Wiley, Benita S. Katzenellenbogen> ;Breast Cancer Research and Treatment. 2013 Feb 1
12 citations
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/...
Kostandinos Sideras, Amylou C. Dueck, Timothy J. Hobday, Kendrith M. Rowland, Jacob B. Allred, Donald W. Northfelt, Wilma L. Lingle, Robert J. Behrens, Tom R. Fitch, D...> ;Clinical Breast Cancer. 2012 Dec 1
37 citations
Brief report: A phase II "window-of-opportunity" frontline study of the mTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG ...
Thanyanan Reungwetwattana, Julian R. Molina, Sumithra J. Mandrekar, Katie Allen-Ziegler, Kendrith M. Rowland, Nicholas F. Reuter, R. F. Luyun, Grace K. Dy, Randolph S....> ;Journal of Thoracic Oncology. 2012 May 1
32 citations
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
M. Catherine Pietanza, Shirish M. Gadgeel, Afshin Dowlati, Thomas J. Lynch, Ravi Salgia, Kendrith M. Rowland, Michael S. Wertheim, Katharine A.R. Price, Gregory J. Rie...> ;Journal of Thoracic Oncology. 2012 May 1
120 citations
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial
Lisa A. Kottschade, Jeff A. Sloan, Miroslaw Mazurczak, David B. Johnson, Bronagh P. Murphy, Kendrith M. Rowland, De Anne A. Smith, Alan R. Berg, Philip J. Stella, Char...> ;Supportive Care in Cancer. 2011 Nov 1
41 citations
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treat...
Aminah Jatoi, Shaker R. Dakhil, Jeff A. Sloan, John W. Kugler, Kendrith M. Rowland, Paul L. Schaefer, Paul J. Novotny, Donald B. Wender, Howard M. Gross, Charles L. Lo...> ;Supportive Care in Cancer. 2011 Oct 1
48 citations
Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients with Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma
S. John Weroha, Ann L. Oberg, Katie L. Allen Ziegler, Shaker R. Dakhilm, Kendrith M. Rowland, L. C. Hartmann, Dennis F. Moore, Gary L. Keeney, Prema P. Peethambaram, P...> ;Gynecologic Oncology. 2011 Jul 1
167 citations
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
Debra L. Barton, Edward J. Wos, R. Qin, Bassam I. Mattar, Nathan Benjamin Green, Keith S. Lanier, James D. Bearden, John W. Kugler, Kay L. Hoff, Pavan S. Reddy, Kendri...> ;Supportive Care in Cancer. 2011 Jun 1
A randomized phase II study of pemetrexed (PEM) with or without sorafenib (S) as second-line therapy in advanced non-small cell lung cancer (NSCLC) of nonsquamous hist...
Molina JR, Dy GK, Foster NR, Allen Ziegler KL, Adjei A, Rowland KM, Aubry M, Flynn PJ, Mandrekar SJ, Schild SE, Adjei AA> ;J. Clin. Oncol.. 2011-05-20
Join now to see all

Grant Support

Carle Cancer Center Community Clinical Oncology ProgramNational Cancer Institute2004–2011
Carle Cancer Center Community Clinical Oncology ProgramNational Cancer Institute2000–2003

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Carle Foundation HospitalUrbana, Illinois
Gibson Area Hospital and Health ServicesGibson City, Illinois